FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers

December 28, 2017 -- Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. “Diabetes is the leading cause of lower limb amputations,”...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news